Search

Connext TV

© Abbott 2023. All rights reserved. 9-EH-5-14558-01 09-2023
Overview

THE PIONEER IN VENTRICULAR SEPTAL OCCLUDERS1 Abbott’s Amplatzer line not only pioneered structural heart defect occluders, it also retains a leadership position in structural heart innovation and…
Patients who benefit

The importance of treating patients with VSD AFTER RECEIVING THE AMPLATZER™ VSD OCCLUDER JOZEF, AMAZED AT HIS ENERGY AND ABILITY TO WALK LONG DISTANCES AGAIN, SAID: “I feel joy deep inside…
Key Features

Choose between two Amplatzer™ devices for Muscular VSD Closure Abbott’s 2 muscular VSD occluders allow for either a femoral or an arterial delivery. Amplatzer™ Muscular VSD Occluder …
Clinical Data

AMPLATZER™ MUSCULAR VSD OCCLUDER DEMONSTRATED CLOSURE SUCCESS IN PATIENTS WITH VSD The Amplatzer™ Muscular VSD Occluder was evaluated in a prospective, non-randomized, multi-center clinical study…
Guidelines & Recommendations

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PFO closure COMPELLING DATA RESULTED IN POSITIVE GUIDELINES RECOMMENDING PFO…
Diagnosis & Prevention

SWITCH TO THE interventional VIEW For more information specific to interventional cardiology regarding PFO closure Characteristics that are strongly associated with a causal role of…
Tailor/Séguin/Rigid Saddle

MITRAL VALVE REPAIR SOLUTIONS Abbott’s customizable mitral valve repair products are suitable for implant using open sternotomy and minimally invasive approaches such as robotic surgery. THE…
Overview

PREVENT HEART FAILURE HOSPITALIZATIONS BY REMOTELY MANAGING PULMONARY ARTERY (PA) PRESSURE WITH THE CARDIOMEMS HF SYSTEM Abbott’s CardioMEMS™ HF System is the leading remote monitoring platform for…
Patients who benefit

PATIENT SELECTION AND ASSESSMENT SELECTING THE RIGHT PATIENT The CardioMEMS™ heart failure (HF) System is indicated for patients with:1 New York Heart Association (NYHA) Class Class III heart…